Phase II clinical trial assessing the addition of hyperthermia to salvage concurrent chemoradiotherapy for unresectable recurrent head and neck cancer in previously irradiated patients
Abstract Background This single-arm phase II trial aimed to assess the effectiveness and safety of incorporating hyperthermia into salvage concurrent chemoradiotherapy (CCRT) for previously irradiated unresectable recurrent head and neck cancer. Methods We enrolled patients with non-metastatic recur...
Saved in:
Main Authors: | Kai-Lin Yang, Mau-Shin Chi, Chung-Yu Hao, Hui-Ling Ko, Yi-Ying Huang, Ren-Hong Wu, Hung-Chih Lai, Ying-Chu Lin, Sheng-Po Hao, Kwan-Hwa Chi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13014-025-02585-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of primary tumor volume on survival of concurrent chemoradiotherapy in stage IV non‐small cell lung cancer
by: Xiaxia Chen, et al.
Published: (2024-09-01) -
Enhancing magnetic hyperthermia: Investigating iron oxide nanoparticle coating and stability
by: Joana Santos, et al.
Published: (2025-01-01) -
Effect of chemoradiotherapy on the dynamics of circulating lymphocyte subsets in patients with non-metastatic nasopharyngeal carcinoma
by: Lilan Yi, et al.
Published: (2025-02-01) -
Novel cisplatin-magnetoliposome complex shows enhanced antitumor activity via Hyperthermia
by: M. Carmen Jiménez-López, et al.
Published: (2025-02-01) -
Research trends in glioma chemoradiotherapy resistance: a bibliometric analysis (2003–2023)
by: Shishi Yu, et al.
Published: (2025-02-01)